The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Market Size Of The Oxycodone Drugs Market In 2026 And What Value Is Projected For 2030?
The oxycodone drugs market has experienced substantial growth in recent years. It is projected to increase from $5.98 billion in 2025 to $6.38 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.7%. This historic expansion can be attributed to the widespread occurrence of moderate to severe pain conditions, the extensive application of opioids in post-operative care, robust hospital demand for injectable analgesics, the proven clinical efficacy of oxycodone, and the limited availability of alternative pain therapies.
The oxycodone drugs market is anticipated to exhibit robust growth over the next few years. This market is projected to expand to $8.07 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.1%. The expansion during the forecast period is attributable to stricter regulations concerning opioid prescriptions, the increasing prevalence of controlled-release pain management, a rise in cancer and chronic pain conditions, the proliferation of pain management clinics, and advancements in safer opioid formulations. Significant trends expected in the forecast period include a shift towards abuse-deterrent oxycodone formulations, an increased adoption of extended-release pain management therapies, a growing preference for opioid administration in hospital environments, a heightened emphasis on prescription monitoring and compliance, and the broader availability of generic oxycodone products in regulated markets.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15886&type=smp
Which Growth Drivers Are Contributing To The Progress Of The Oxycodone Drugs Market?
The increasing prevalence of orthopedic conditions is anticipated to drive the expansion of the oxycodone drug market in the future. Orthopedic disorders encompass ailments impacting bones, joints, ligaments, tendons, and muscles, frequently leading to persistent pain, restricted movement, and enduring functional impairments. The escalation in orthopedic issues stems from elements like an aging population, inactive routines, obesity, injuries from sports, and job-related stress. Oxycodone medications facilitate efficient pain control, offering alleviation for both acute and chronic orthopedic discomfort, such as from fractures, joint deterioration, and after operations, by influencing pain receptors within the central nervous system. For example, as reported in February 2024 by Arthritis Australia, an Australia-based non-profit organization, it is projected that in 2025, an estimated 212,136 males and 362,137 females will have rheumatoid arthritis (RA), with these figures anticipated to climb by 2040 to approximately 280,040 males and 479,828 females. Consequently, the increasing prevalence of orthopedic conditions is fueling the expansion of the oxycodone drug market.
What Are The Key Segments Of The Oxycodone Drugs Market?
The oxycodone drugs market covered in this report is segmented –
1) By Drug Type: Short Acting Oxycodone, Long Acting Oxycodone
2) By Dosage Form: Tablets, Capsules, Injections
3) By Indication: Neuropathic Pain, Musculoskeletal Pain, Cancer Pain, Post Operative Pain, Other Indications
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Short Acting Oxycodone: Immediate-Release Oxycodone Tablets, Oxycodone Oral Solution
2) By Long Acting Oxycodone: Extended-Release Oxycodone Tablets, Oxycodone Controlled-Release Formulations
What Key Trends Are Influencing The Development Of The Oxycodone Drugs Market?
Major companies operating in the oxycodone drug market are prioritizing the creation of advanced abuse-deterrent immediate-release (IR) formulations to reduce the risk of misuse via injection and intranasal administration. Abuse-deterrent IR opioids incorporate physical and chemical barriers, making tablets difficult to crush, dissolve, or manipulate for non-oral routes, which in turn enhances patient safety and minimizes diversion. For instance, in October 2024, Protega Pharmaceuticals LLC, a US-based pharmaceutical company, received FDA approval for ROXYBOND™ (oxycodone hydrochloride) 10 mg immediate-release tablets, incorporating patented SentryBond abuse-deterrent technology. This technology is engineered to resist physical manipulation and chemical extraction, rendering the tablets difficult to cut, crush, or dissolve for misuse through intranasal or intravenous routes. As a result, it lowers the potential for abuse while still delivering effective immediate-release pain relief for patients whose severe pain requires opioid therapy when other treatment options are insufficient.
Who Are The Leading Companies Operating In The Oxycodone Drugs Market?
Major companies operating in the oxycodone drugs market are Pfizer Inc., Johnson & Johnson Services Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd, Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd, Purdue Pharma L.P, Endo International plc, Amneal Pharmaceuticals LLC, Mundipharma Pty Limited, Alkermes plc, Mallinckrodt Pharmaceuticals, Alvogen Group Inc., Collegium Pharmaceutical Inc., Lannett Company Inc., Acorda Therapeutics Inc., Camurus AB, Rhodes Pharmaceuticals L.P., KVK Tech Inc., Teikoku Pharma USA Inc., Manus Aktteva Biopharma LLP, Zyla Life Sciences
Read the full oxycodone drugs market report here:
https://www.thebusinessresearchcompany.com/report/oxycodone-drugs-global-market-report
What Are The Leading Geographic Regions In The Oxycodone Drugs Market?
North America was the largest region in the oxycodone drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oxycodone drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Oxycodone Drugs Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=15886&type=smp
Browse Through More Reports Similar to the Global Oxycodone Drugs Market 2026, By The Business Research Company
Oxycodone Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/oxycodone-drugs-global-market-report
Morphine Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/morphine-drugs-global-market-report
Narcotic Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/narcotic-drugs-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model